Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study

Overview of attention for article published in The Journal of Headache and Pain, December 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,682 followers.

【コホート研究】1年間のエレヌマブ/ガルカネズマブ治療を受けた患者において、その中止1ヶ月-3ヶ月後、月間片頭痛日数は徐々に増加したが、ベースラインよりも少なかった。 #ペ読 https://t.co/TZrsoRMSR1

26 Dec 2021

Reply Repost Favourite

RT @NeuroPsychBMC: Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohor…

19 Dec 2021

Reply Repost Favourite

Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study https://t.co/5rM9xXatj1

19 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.